Researchers from McMaster University have manufactured a new antibacterial gel consisting entirely of bacteria-killing viruses. The new gel opens new doors for phage research in the era of antimicrobial resistance.
Yersinia pathogens inject the enzyme YopO into the macrophages of the immune system, preventing the defense cells from digesting the plague bacteria. This article outlines a study done on the ability of YopO to change its shape and confuse the immune system, allowing for a more targeted approach to treatment and possible eradication of Yersinia.
Treatment with BAT® [Botulism Antitoxin Heptavalent (Equine)] was associated with shorter hospital and intensive care unit stays.
The US Department of Health and Human Services (HHS) awarded a contract for $535 to Emergent BioSolutions Inc. for Vaccinia Immune Globulin Intravenous (VIGIV) to be used in the Strategic National Stockpile. VIGIV is the only therapeutic licensed by the US Food and Drug Administration (FDA) for the treatment of complications due to smallpox vaccination.
In a new study, remdesivir, an experimental antiviral drug, completely protected four African green monkeys from a lethal dose of Nipah virus,
Researchers say the discovery of a “hidden target” on the surface of the influenza A virus could lead to better ways to prevent and treat the flu.
Early Middle East respiratory syndrome (MERS) diagnosis may require more sensitive risk assessment tools to reduce delays related to patients and health system.
Researchers have developed a simple model that characterizes the biomechanics of Ebola virus-host cell adhesion, findings that could provide new and helpful information on the road to developing an effective Ebola treatment.
In a breakthrough with applicability across many flu strains, researchers find a potential small molecule that mimics antibodies to treat disease.
The development and ultimate approval of tecovirimat for the antiviral treatment of smallpox, a disease that has been eradicated from the world for nearly 40 years, required a unique regulatory approach based on the US Food and Drug Administration's Animal Rule.